Understand the source comparison
Visceral vs Subcutaneous Fat Loss — Why the Timeline Differs
Visceral adipose tissue (VAT) and subcutaneous adipose tissue (SAT) respond differently to growth hormone-mediated lipolysis because of receptor density differences. VAT contains approximately 30–50% more beta-adrenergic receptors per adipocyte than SAT, makin
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- Visceral adipose tissue (VAT) and subcutaneous adipose tissue (SAT) respond differently to growth hormone-mediated lipolysis because of receptor density differences. VAT contains approximately 30–50% more beta-adrenergic receptors per adipocyte than SAT, making it more responsive to catecholamine-driven lipolysis triggered by elevated GH and IGF-1. Research published in the Journal of Clinical Endocrinology & Metabolism found that GH replacement therapy in GH-deficient adults reduced VAT by an average of 18% over 12 weeks, while SAT reduction was only 6% in the same period.
- This differential response creates a timeline where metabolic health improvements. Reduced fasting insulin, improved glucose disposal, lower triglycerides. Appear within 4–8 weeks, before visible changes in body composition. A subject using hexarelin at 300mcg twice daily might see fasting insulin drop from 12 mIU/L to 8 mIU/L and waist circumference decrease by 2–3 cm within six weeks, while overall body fat percentage measured by DEXA only drops 1–2%. The visceral fat is mobilizing faster, but it's internal and not visible in the mirror.
- The practical implication: don't rely on appearance alone to assess hexarelin fat loss results timeline. DEXA scans, waist-to-hip ratio measurements, and metabolic bloodwork (fasting insulin, HbA1c, lipid panel) are far more sensitive markers of early-phase fat loss than visual assessment or standard bathroom scales. We've seen researchers dismiss hexarelin as ineffective at week 6 based on mirror assessment alone, when DEXA data showed significant VAT reduction already underway.